Recent Updates

Modified on: 
Sep 10, 2021

The content on this page is specific for 2021-2022 Transfusion Camp. Content for 2022-2023 will start being updated approximately one month ahead of the live event held in Toronto. See General Information Schedules and Locations document for live event dates.

Reminder:

Transfusion
Modified on: 
Sep 10, 2021

The content on this page is specific for 2021-2022 Transfusion Camp. Content for 2022-2023 will start being updated approximately one month ahead of the live event held in Toronto. See General Information Schedules and Locations document for live event dates.

Reminder:

Transfusion
Modified on: 
Sep 10, 2021

The content on this page is specific for 2021-2022 Transfusion Camp. Content for 2022-2023 will start being updated approximately one month ahead of the live event held in Toronto. See General Information Schedules and Locations document for live event dates.

Transfusion
Modified on: 
Sep 10, 2021

The content on this page is specific for 2021-22 Transfusion Camp. Content for 2022-2023 will start being updated approximately one month ahead of the live event held in Toronto. See General Information Schedules and Locations document for live event dates.

Reminder:

Transfusion
Modified on: 
Sep 10, 2021

Transfusion Camp is a 5-day education program aimed at increasing knowledge of transfusion medicine and best practices by providing high-quality training to post-graduate medical trainees in various specialties related to transfusion.

Led by transfusion experts at the University of Toronto, Transfusion Camp is delivered to trainees from more than 12 different specialty training programs at more than 15 universities in Canada and abroad.

Transfusion
Modified on: 
Sep 9, 2021

The Donation and Transplant Administrators Advisory Committee (DTAAC) identifies and provides end-to-end operational, financial and policy advice to inform the development of nationally mandated initiatives to allow issues to be addressed and all requirements gathered in advance of the full development and roll-out with donation and transplant programs participating in interprovincial activities.

Organs and Tissues
Modified on: 
Sep 9, 2021

Transfusion-related acute lung injury (TRALI) is a rare but serious syndrome characterized by sudden acute respiratory distress following transfusion. It is defined as new, acute respiratory distress during or within six hours of blood component (i.e., red blood cells, plasma, platelets) or blood product (i.e., plasma protein product) administration in the absence of temporally-associated risk factors for acute respiratory distress syndrome (ARDS). All plasma-containing blood components and plasma protein products have been implicated in TRALI, including rare reports with intravenous immunoglobulin (IVIg) and cryoprecipitate. Despite the very small amount of plasma contained in red blood cells, this component is associated with the largest number of reported cases of TRALI. TRALI is thought to be caused by activation of recipient neutrophils by donor-derived antibodies targeting human leukocyte antigens (HLA) or human neutrophil antigens (HNA). Non-antibody-mediated cases also occur and may be mediated by biologic response modifiers present in the transfused blood component or plasma protein product, along with recipient factors.

Transfusion
Modified on: 
Sep 8, 2021

This Fall, we’re working to raise national awareness about living kidney donation.​ ​To help support our collective efforts to raise awareness, we’ve pulled together some messaging and digi

Organs and Tissues
Modified on: 
Aug 27, 2021

The Public Education and Awareness Committee (PEAC) facilitates interprovincial collaboration in the development and implementation of public education and awareness strategies. Organ donation and transplantation is complex and not well understood by the public. There are many misconceptions that contribute to barriers to registering intent to donate or consenting to donation.

Organs and Tissues
Modified on: 
Aug 27, 2021

This annual report describes surveillance of transmissible blood-borne infections and emerging threats of concern. High quality and timely surveillance is central to the safety of the blood supply. This includes monitoring of transmissible disease markers that the blood is tested for and investigation of any reports of possible transfusion transmission, as well as a horizon scan for any new pathogens that may pose a risk. Non-infectious surveillance of aspects of donor health and safety as well as diagnostic services are also included.

Transfusion

Pages